Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
987.3 ILa | -3.11% | -1.86% | -25.99% |
19/03 | C-Lab Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | C-Lab Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 162.7 | 134.2 | 113.1 |
Enterprise Value (EV) 1 | 155 | 112.9 | 91.68 |
P/E ratio | 137 x | 19.3 x | 5.51 x |
Yield | - | - | - |
Capitalization / Revenue | 1.95 x | 1.13 x | 0.87 x |
EV / Revenue | 1.86 x | 0.95 x | 0.71 x |
EV / EBITDA | 38 x | 12.1 x | 4 x |
EV / FCF | -2,43,33,699 x | 1,58,04,646 x | -1,81,40,563 x |
FCF Yield | -0% | 0% | -0% |
Price to Book | 3.46 x | 2.22 x | 1.37 x |
Nbr of stocks (in thousands) | 8,480 | 8,480 | 8,480 |
Reference price 2 | 19.19 | 15.83 | 13.34 |
Announcement Date | 28/03/22 | 22/03/23 | 19/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 96.79 | 107.2 | 105.3 | 83.32 | 119.3 | 130 |
EBITDA 1 | 4.313 | 9.367 | 14.52 | 4.078 | 9.352 | 22.93 |
EBIT 1 | 1.692 | 6.813 | 12.16 | 1.752 | 6.919 | 20.1 |
Operating Margin | 1.75% | 6.35% | 11.55% | 2.1% | 5.8% | 15.46% |
Earnings before Tax (EBT) 1 | 1.616 | 5.4 | 11.52 | 1.628 | 6.662 | 20.26 |
Net income 1 | 1.416 | 5.46 | 11.46 | 1.177 | 6.984 | 20.52 |
Net margin | 1.46% | 5.09% | 10.88% | 1.41% | 5.85% | 15.78% |
EPS 2 | 0.1669 | 0.6438 | 1.350 | 0.1400 | 0.8200 | 2.420 |
Free Cash Flow | - | -0.9262 | 17.45 | -6.369 | 7.146 | -5.054 |
FCF margin | - | -0.86% | 16.57% | -7.64% | 5.99% | -3.89% |
FCF Conversion (EBITDA) | - | - | 120.19% | - | 76.41% | - |
FCF Conversion (Net income) | - | - | 152.33% | - | 102.32% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 08/02/21 | 08/02/21 | 22/03/21 | 28/03/22 | 22/03/23 | 19/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 18.9 | 17.9 | - | - | - | - |
Net Cash position 1 | - | - | 2.96 | 7.75 | 21.3 | 21.5 |
Leverage (Debt/EBITDA) | 4.38 x | 1.915 x | - | - | - | - |
Free Cash Flow | - | -0.93 | 17.5 | -6.37 | 7.15 | -5.05 |
ROE (net income / shareholders' equity) | - | 18.9% | 32.9% | 2.73% | 13% | 28.7% |
ROA (Net income/ Total Assets) | - | 5.03% | 9.02% | 1.24% | 3.97% | 10.3% |
Assets 1 | - | 108.6 | 127 | 95.14 | 175.9 | 199.6 |
Book Value Per Share 2 | 3.220 | 3.580 | 4.620 | 5.550 | 7.140 | 9.740 |
Cash Flow per Share 2 | 0.3600 | 0.1800 | 1.860 | 0.9100 | 2.510 | 2.530 |
Capex 1 | 0.64 | 5.62 | 0.98 | 1.3 | 0.24 | 1.14 |
Capex / Sales | 0.66% | 5.24% | 0.93% | 1.56% | 0.2% | 0.88% |
Announcement Date | 08/02/21 | 08/02/21 | 22/03/21 | 28/03/22 | 22/03/23 | 19/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-25.99% | 2.25Cr | |
+76.44% | 9.57TCr | |
+27.21% | 2.81TCr | |
+21.66% | 2.18TCr | |
-1.65% | 1.71TCr | |
+10.81% | 1.52TCr | |
+0.82% | 1.13TCr | |
+20.76% | 1.11TCr | |
+10.04% | 961.4Cr | |
+32.30% | 949.75Cr |
- Stock Market
- Equities
- CLAB Stock
- Financials C-Lab Ltd